Back to first-pass browser

First-pass extracted concept

in vivo CAR engineering

Candidate: concept label1 source documents3 linked claims
Jump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Evidence Snippets

In vivo CAR engineering is an emerging therapeutic platform for cancer and autoimmune diseases.
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1clinical translation statussupports2025Source 1DOIPubMed

In vivo CAR engineering has progressed to early clinical testing with initial safety and efficacy reported.

Claim 2enabling delivery modalitiessupports2025Source 1DOIPubMed

Advanced delivery systems including immune-evasive lentiviral vectors and targeted lipid nanoparticles enable in vivo CAR engineering.

Claim 3therapeutic platform statussupports2025Source 1DOIPubMed

In vivo CAR engineering is an emerging therapeutic platform for cancer and autoimmune diseases.